KEY ARCHIVE FOR
THE PAST 8-12
WEEKS
HYPERTENSION
DIALYSIS-CRF
CLINICAL NEPHR
FOR NURSES
FREE ZONE
KEY ZONE
SEARCH FOR A TALK
June 16, 2019
Advances in Chronic Kidney Disease 2018
Renal Research Institute (Lake Buena Vista, FL; February, 2018)  

PARTS 8 and 9

Keynote Lecture: Tissue sodium - quo vadis?
Jens Titze, MD

Renal functional reserve and kidney stress test in the evaluation of kidney function in different conditions
Claudio Ronco, MD

The fluid overload- inflammation axis
Jeroen Kooman, MD

Can we stop infections in dialysis?
Alan S. Kliger, MD

Blood volume and fluid management
Priscila Preciado, MD

Closing Ceremony
Peter Kotanko, MD

Harvard Intensive Review of Nephrology 2018
Brigham and Women's Hospital Department of Medicine (Boston, MA; August, 2018)  

PART 1

Basic Concepts of Immunology in Autoimmune Kidney Disease
Ramon Bonegio, MD



WILEY PUBLISHING, publishers of many journals and books of interest to kidney disease professionals, including the journals Am J Transplantation, Seminars in Dialysis, and Hemodialysis International.
For more information about Wiley Publishing please visit
http://www.wiley.com/WileyCDA/Section/id-351440.html

Editor's Announcement

DON'T FORGET THE HARVARD BOARD REVIEW COURSE THIS YEAR !

Intensive Review of Nephrology
Fairmont Copley Plaza Aug 5 - 9, 2019
Boston, MA

Program link

Intensive Review of Nephrology

The Comprehensive Clinical Update and Board Review

With over 70 interactive lectures, case discussions, and board preparation sessions, this CME program provides a comprehensive review of state-of-the-art nephrology practices offered by the clinical faculty of Harvard Medical School.

It offers accelerated learning for:

Clinicians seeking a practical and comprehensive review that ensures they are up to date across all major areas of nephrology:
  1. The latest options for diagnosis: what to choose, when, and why
  2. Current evidence-based treatment and care management strategies to optimize patient outcomes
  3. Improved approaches to common and complex clinical challenges
  4. Navigating clinical controversies
  5. How to avoid medical mistakes
Physicians preparing to certify or recertify and are seeking a thorough, proven preparatory course in advance of their taking the Nephrology ABIM board examination.

 


Schedules for self-monitoring blood pressure: a systematic review (Am J Hypertens)
Inverse relationship between coarse food grain intake and blood pressure among young Chinese adults (Am J Hypertens)
Serum lipids and risk of rapid renal function decline in treated hypertensive adults with normal renal function (Am J Hypertens)
KDOQI US commentary on the 2017 ACC/AHA hypertension guideline (Am J Kidney Dis)
Comparison of 24-hour and office pulse wave velocity for prediction of mortality in hemodialysis patients (Am J Nephrol)
Antihyperglycemic and blood pressure effects of empagliflozin in Black patients with type 2 diabetes mellitus and hypertension (Circulation)
Twenty-four-hour blood pressure-lowering effect of a sodium-glucose cotransporter 2 inhibitor in patients with diabetes and uncontrolled nocturnal hypertension (Circulation)
Possible mechanism of hematocrit elevation by sodium glucose cotransporter 2 inhibitors and associated beneficial renal and cardiovascular effects (Circulation)
Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 DM (Circulation)
Secondhand smoke and CKD (Clin J Am Soc Nephrol)
Research recommendations from the National Institutes of Health workshop on predicting, preventing, and treating preeclampsia (Hypertens)
US Renal Data System 2018: Annual Data Report: Epidemiology of kidney disease in the United States (Am J Kidney Dis)
Muscle relaxant use among hemodialysis patients: prevalence, clinical indications, and adverse outcomes (Am J Kidney Dis)
Associations of serum and dialysate electrolytes with QT interval and prolongation in incident hemodialysis: the Predictors of Arrhythmic and Cardiovascular Risk in ESRD (PACE) Study (BMC Nephrol)
Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: A Scientific Statement From the American Heart Association (Circulation)
Membranous nephropathy due to chronic mercury poisoning from traditional Indian medicines: report of five cases (Clin Kidney J)
The effect of blood flow rate on dialysis recovery time in patients undergoing maintenance hemodialysis: A prospective, parallel-group, randomized controlled trial (Hemodial Int)
Comparative cardiac safety of selective serotonin reuptake inhibitors among individuals receiving maintenance hemodialysis (J Am Soc Nephrol)
Efficacy and safety of tenapanor in patients with hyperphosphatemia receiving maintenance hemodialysis: a randomized phase 3 trial (J Am Soc Nephrol)
Effects of hemodiafiltration versus conventional hemodialysis in children with ESKD: The HDF, Heart and Height Study (J Am Soc Nephrol)
Association of urinary oxalate excretion with the risk of chronic kidney disease progression (JAMA Intern Med)
Safety and cardiovascular efficacy of spironolactone in dialysis- dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial (Kidney Int)
Increasing access to integrated ESKD care as part of universal health coverage (Kidney Int)
A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients (Kidney Int)
Beta-blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double- blind, placebo-controlled, multicentre trial (Lancet)
Serum phosphate optimal timing and range associated with patients survival in haemodialysis: the COSMOS study (Nephrol Dial Transplant)
Intravenous sodium bicarbonate in treating patients with severe metabolic acidemia (Am J Kidney Dis)
Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD) (BMC Nephrol)
Kidney xenotransplantation (Clin J Am Soc Nephrol)
Monogenic causes of chronic kidney disease in adults (Kidney Int)
A new edition of the Declaration of Istanbul: updated guidance to combat organ trafficking and transplant tourism worldwide (Kidney Int)


 2018
 

 H: Pathophysiology -- Salt (sodium, chloride) sensitivity
Multiple Spot Urine Sampling Is More Precise, Accurate, and Simpler Compared to 24-Hours Collection for Estimating Sodium Excretion
Effect of Dietary Salt Intake on Renal Outcomes in Advanced CKD Patients
 H: Pathophysiology -- Endothelium, Nitric Oxide
Efficacy and Safety of Endothelin Receptor Antagonist on Renal Outcomes
 H: Pathophysiology -- Stroke
Renal Impairment Modifies the Association Between Sodium Intake and Risk of Stroke ? An Analysis of INTERSTROKE
Association of Vascular Calcification with Brain Atrophy in Patients with CKD: Cross-Sectional and Longitudinal Analyses
 H: Diagnosis -- Preadolescent and adolescent
Office Blood Pressure Measurement (OBPM) in Children: The SPA Project
 H: Special problems -- Patients with lipid disorders
The Association of Fenofibrate with Kidney Tubular Injury in a Subgroup of Participants in the ACCORD Trial
 H: Special problems -- Endocrine hypertension
Thyroid Status and Coronary Artery Calcification in a Prospective Hemodialysis Cohort
Association of Thyroid Function with Prevalence and Development of CKD
A Dose Dependent Relationship Between Hypothyroidism and CKD within a Real- World Clinical Environment
 H: Special problems -- Smoking, ethanol, substance abuse
Marijuana Use and Kidney Outcomes in the ASSESS-AKI Cohort
Cannabis Use and Its Association with eGFR Decline in Advanced CKD Patients Transitioning to ESRD
 H: Special problems -- Obesity, Insulin Resistance
The Relationship Between Body Mass Index (BMI) and Outcomes in Health and CKD
Hypoglycemia Is Common in Patients with Type 2 Diabetes and CKD

 Basic hemodialysis -- New dialysis methods, hemodiafiltration
Quantification of Internal Filtration in Hollow Fiber Hemodialyzers with Medium Cut-Off Membrane
 CRF: Problem Areas -- Outcomes (Morbidity, Mortality)
Association of Hyperuricemia and Serum Uric Acid Lowering Medication with Mortality in Hemodialysis Patients
Association Between Religiosity and Risk of End-Stage Kidney Disease (ESKD) Among Blacks and Whites in the Southeastern United States
 CRF by problem area -- Cost effectiveness, CQI, Guidelines
Tele-Nephrology to Provide Efficient and Patient-Centered Ambulatory Care
Quality of Life in CKD Patients with Hyperkalemia in the US: Results from the KDQOL-36
 CRF by problem area -- Etiology
Survey of Migrant Dialysis Patients Discloses a Majority with Paraquat or Other Agrochemical Exposure: A Potential Etiology for CKDu
Chronic Interstitial Nephritis in Agricultural Communities (CINAC) Is Strongly Associated with Pesticides
KIM-1 as an Early Biomarker of Kidney Injury in Agricultural Communities in Sri Lanka
 CRF by problem area -- Progression
Physical Activity Is Associated with the Incident CKD in Subjects with Normal Renal Function: Community Based Prospective Cohort Study
A Machine Learning Approach to Identifying Patients at Risk of Developing Incident CKD
 CRF by problem area -- Infections (other than hepatitis, peritonitis)
Effect of Treatment of Chronic Hepatitis C Virus (HCV) Infection with Glecaprevir/Pibrentasvir (G/P) on Renal Biomarkers in Patients with CKD Stage 3b, 4, or 5
Effect of Ledipasvir and Sofosbuvir (LDV/SOF) on Kidney Function and Urinary Biomarkers in Patients (Pts) with Proteinuric CKD
 CRF by problem area -- Anemia/Erythropoietin/Iron
Molidustat, a Daily Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, and Vascular Endothelial Growth Factor in Patients with CKD
 CRF by problem area -- Drug use in CRF
Discontinuation of Proton Pump Inhibitors in Patients with CKD
 CRF by organ system -- Cardiovascular/Hypertension
Dialysis Modality and Risk of Atrial Fibrillation: A Systematic Review and Meta-Analysis
Direct Oral Anticoagulants vs Warfarin Across CKD Stages: Mortality Outcomes in US Veterans
 CRF by organ system -- Psychiatric
Inflammatory Biomarkers Improve Prediction of Sertraline Treatment Response in CKD

 Assessing renal function -- Creatinine clearance
Effect of Exercise Intensity on Autoregulation of GFR in Patients with CKD Stage 2
 Acid-base/Lytes -- Metabolic acidosis
Urine Citrate Excretion Non-Invasively Verifies Reduced Acid Retention in Response to Dietary Acid Reduction in CKD 2 Patients Without Metabolic Acidosis
Urine Chloride levels Are Associated with CKD Progression in CKD Patients
Serum Chloride Associates with CKD Progression
Association of Serum Bicarbonate Levels with Kidney Function Decline in Patients with Polycystic Kidney Disease
 Acid-base/Lytes -- Hypomagnesemia
Serum Magnesium Levels and Subsequent Risk of Peripheral Artery Disease
 Assessing renal function -- Urine/plasma creatinine, osmolality, sodium, urea
Loop Diuretic Challenge to Predict the Need for Renal Replacement Therapy Among Patients with Stage III AKI
 Assessing renal function -- Urinary sediment in ARF
Diagnostic Utility of Serial Microscopic Examination of the Urinary Sediment in AKI
 ARF etiology -- Radiocontrast media
Assessment of Utility of Urine Sediment Microscopy in Hepatorenal AKI
Impact of Porto-Pulmonary Hypertension in the Course of Hepatorenal AKI
Post-AKI eGFR and ACR and Future Risk of Kidney Disease Progression
 Proteinuria/Hematuria -- Membranous GN
Differences in Outcome in Patients with Membranous Nephropathy with and Without Anti-PLA2R Antibodies
Levels of Anti-PLA2R Antibodies Predictive of Renal Prognosis in Japanese Patients with PLA2R-Associated Primary Membranous Nephropathy
Treatment Patterns Among Adults with Membranous Nephropathy in the Cure Glomerulopathy Network (CureGN)
Immunosuppressive Therapy for Children with Membranous Nephropathy: A Report from the Cure Glomerulopathy Network (CureGN)
Mycophenolate Mofetil and Tacrolimus versus Tacrolimus Alone for the Treatment of Idiopathic Membranous Glomerulonephritis: A Randomised Controlled Trial
 Proteinuria/Hematuria -- Amyloidosis, fibrillary, immunotactoid
Bortezomib in the Treatment of Kidney Light Chain Amyloidosis
 Cystic disease -- Hereditary polycystic disease
Primary Efficacy Analyses from a Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients with Autosomal Dominant Polycystic Kidney Disease
 Cancer -- Renal and urinary tract cancers
A Worrisome Explosion: Time Series Analysis of Kidney Cancer Incidence in the United States

ADVERTISEMENT